Hangzhou Binjiang 5050 Fund
VC Fund
Hangzhou Binjiang 5050 Fund is an investment fund.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Hangzhou Binjiang 5050 Fund invests in
Stages Hangzhou Binjiang 5050 Fund invests in
Countries Hangzhou Binjiang 5050 Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Chen Yichao
|
|||
Investment Focus
Industry
- Medical 2 (67%)
- Biotechnology 2 (67%)
- Hospital 1 (33%)
- Biopharma 1 (33%)
- Therapeutics 1 (33%)
Stage
- Series A 2 (67%)
- Angel 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chen Yichao
Investor
|
Investor | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Jingjiahang
|
Jingjiahang is a cutting-edge biopharmaceutical company dedicated to the pioneering research, development, and commercialization of innovative new targeted radiopharmaceuticals. With a deep commitment to advancing precision medicine, Jingjiahang focuses on creating highly effective therapeutic solutions that are specifically designed to target andtreat various types of cancer and other serious diseases. | Angel / Jun 13, 2025 | |
Imbioray
|
Imbioray is a biotechnology company that specializes in cellular immunotherapy for tumors and immune diseases. The company engages in the development of global CAR-NK and tiNK cell therapy drugs and is committed to solving the treatment of clinically unmet diseases. | $13.5M / Series A / Jan 21, 2025 | |
St Phi Therapeutics
|
Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy. | $13.8M / Series A / Apr 15, 2024 |
Co-Investors
Tailong Investment
2 deals together
Huayi Capital
1 deal together
Sinowisdom
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Hangzhou Binjiang 5050 Fund invest in?
Hangzhou Binjiang 5050 Fund invests primarily in Medical, Biotechnology and Hospital startups, most often at Series A and Angel stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Hangzhou Binjiang 5050 Fund?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Hangzhou Binjiang 5050 Fund?
The team at Hangzhou Binjiang 5050 Fund includes Chen Yichao (Investor). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
